NCT03682029 2024-04-17
EVITA
Rigshospitalet, Denmark
Phase NA Active not recruiting
Clinical Trials
7 trialsNCT03999723 2024-04-17
EVI-3
Rigshospitalet, Denmark
Phase 2 Recruiting
NCT03397173 2021-08-11
TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00274820 2020-07-27
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder
Case Comprehensive Cancer Center
Phase 2 Completed
NCT02877277 2018-09-24
EVITA-Pilot
Rigshospitalet, Denmark
Phase NA Completed
NCT00671697 2013-06-04
Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia
Washington University School of Medicine
Phase 1 Completed
NCT00329498 2006-10-26
L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes
Samsung Medical Center
Phase 2 Suspended